Orchestrating the pre-metastatic niche: roles of stromal mediators and immune cells in metastatic progression and therapeutic targeting - Top-Institutions - MDSpire

Orchestrating the pre-metastatic niche: roles of stromal mediators and immune cells in metastatic progression and therapeutic targeting

  • By

  • Yihao Zhai

  • Hao Peng

  • Dayuan Liu

  • Liqiang Huang

  • Hua Zhang

  • Hongli Jiang

  • Baoshou Su

  • Yunxiang Zhong

  • Guolong Deng

  • Ning Li

  • Jigao Feng

  • Caicai Zhang

  • April 30, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Oncology
    • Tumor Microenvironment
    • Immunology

  • #2

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Cancer Biology
    • Immuno-oncology
    • Metastasis Research

  • #3

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Oncology
    • Cancer Immunology
    • Metastasis

  • #4

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Cancer Biology
    • Immunology
    • Metastasis Research

  • #5

    University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center
    University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center

    San Francisco, CA

    Key Differentiators

    • Cancer Immunology
    • Tumor Microenvironment
    • Metastasis

Original Source(s)

Orchestrating the pre-metastatic niche: roles of stromal mediators and immune cells in metastatic progression and therapeutic targeting

  • by Yihao Zhai, Hao Peng, Dayuan Liu, Liqiang Huang, Hua Zhang, Hongli Jiang, Baoshou Su, Yunxiang Zhong, Guolong Deng, Ning Li, Jigao Feng, Caicai Zhang

  • April 30, 2026

Related Content

Emerging applications of artificial intelligence for risk stratification in head and neck cancer: a scoping review

Glioblastoma, IDH-wildtype, with a novel MEF2D-NTRK1 gene fusion: a case report

Bilateral renal metastasis following radical prostatectomy for prostate cancer: a case report